{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:02:41Z","timestamp":1788318161753,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":12,"publisher":"Springer US","isbn-type":[{"value":"9781071650400","type":"print"},{"value":"9781071650417","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5041-7_15","type":"book-chapter","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:55:54Z","timestamp":1778716554000},"page":"317-326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterizing pH-Dependent Interactions Between Immunoglobulin and the Neonatal Fc Receptor Using Surface Plasmon Resonance"],"prefix":"10.1007","author":[{"given":"S\u00e9bastien","family":"Menant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Nevoltris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Ollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"6","key":"15_CR1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cts.12567","volume":"11","author":"M Ovacik","year":"2018","unstructured":"Ovacik M, Lin K (2018) Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development. Clin Transl Sci 11(6):540\u2013552. https:\/\/doi.org\/10.1111\/cts.12567","journal-title":"Clin Transl Sci"},{"issue":"9","key":"15_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","volume":"7","author":"DC Roopenian","year":"2007","unstructured":"Roopenian DC, Akilesh S (2007) FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7(9):715\u2013725. https:\/\/doi.org\/10.1038\/nri2155","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"15_CR3","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.molimm.2005.07.032","volume":"43","author":"B Gurbaxani","year":"2006","unstructured":"Gurbaxani B, Dela Cruz LL, Chintalacharuvu K, Morrison SL (2006) Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life. Mol Immunol 43(9):1462\u20131473. https:\/\/doi.org\/10.1016\/j.molimm.2005.07.032","journal-title":"Mol Immunol"},{"issue":"33","key":"15_CR4","doi-asserted-by":"publisher","first-page":"23514","DOI":"10.1074\/jbc.M604292200","volume":"281","author":"WF Dall'Acqua","year":"2006","unstructured":"Dall'Acqua WF, Kiener PA, Wu H (2006) Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J Biol Chem 281(33):23514\u201323524. https:\/\/doi.org\/10.1074\/jbc.M604292200","journal-title":"J Biol Chem"},{"issue":"19","key":"15_CR5","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1073\/pnas.1408766112","volume":"112","author":"A Schoch","year":"2015","unstructured":"Schoch A, Kettenberger H, Mundigl O, Winter G, Engert J, Heinrich J, Emrich T (2015) Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics. Proc Natl Acad Sci U S A 112(19):5997\u20136002. https:\/\/doi.org\/10.1073\/pnas.1408766112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"15_CR6","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1080\/19420862.2019.1605270","volume":"11","author":"S Chung","year":"2019","unstructured":"Chung S, Nguyen V, Lin YL, Lafrance-Vanasse J, Scales SJ, Lin K, Deng R, Williams K, Sperinde G, Li JJ, Zheng K, Sukumaran S, Tesar D, Ernst JA, Fischer S, Lazar GA, Prabhu S, Song A (2019) An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans. MAbs 11(5):942\u2013955. https:\/\/doi.org\/10.1080\/19420862.2019.1605270","journal-title":"MAbs"},{"issue":"4","key":"15_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.4161\/mabs.28744","volume":"6","author":"T Neuber","year":"2014","unstructured":"Neuber T, Frese K, Jaehrling J, Jager S, Daubert D, Felderer K, Linnemann M, Hohne A, Kaden S, Kolln J, Tiller T, Brocks B, Ostendorp R, Pabst S (2014) Characterization and screening of IgG binding to the neonatal Fc receptor. MAbs 6(4):928\u2013942. https:\/\/doi.org\/10.4161\/mabs.28744","journal-title":"MAbs"},{"issue":"2","key":"15_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/19420862.2016.1261774","volume":"9","author":"X Wang","year":"2017","unstructured":"Wang X, McKay P, Yee LT, Dutina G, Hass PE, Nijem I, Allison D, Cowan KJ, Lin K, Quarmby V, Yang J (2017) Impact of SPR biosensor assay configuration on antibody: neonatal Fc receptor binding data. MAbs 9(2):319\u2013332. https:\/\/doi.org\/10.1080\/19420862.2016.1261774","journal-title":"MAbs"},{"issue":"2","key":"15_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/19420862.2015.1008353","volume":"7","author":"YN Abdiche","year":"2015","unstructured":"Abdiche YN, Yeung YA, Chaparro-Riggers J, Barman I, Strop P, Chin SM, Pham A, Bolton G, McDonough D, Lindquist K, Pons J, Rajpal A (2015) The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity. MAbs 7(2):331\u2013343. https:\/\/doi.org\/10.1080\/19420862.2015.1008353","journal-title":"MAbs"},{"issue":"5","key":"15_CR10","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/19420862.2017.1323160","volume":"9","author":"M Dostalek","year":"2017","unstructured":"Dostalek M, Prueksaritanont T, Kelley RF (2017) Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates. MAbs 9(5):756\u2013766. https:\/\/doi.org\/10.1080\/19420862.2017.1323160","journal-title":"MAbs"},{"key":"15_CR11","unstructured":"Cytiva handbook. Fc receptor binding assays using\u00a0surface plasmon resonance [online]. Available at: https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/digi-34141-pdf."},{"key":"15_CR12","unstructured":"Anna Moberg, Cytiva poster. Facilitating IgG FcRn analyses [online]. Available at: https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/7u38tlpYT0Wp_O6AGG4fNg-pdf."}],"container-title":["Methods in Molecular Biology","Antibody Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5041-7_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:55:55Z","timestamp":1778716555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5041-7_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650400","9781071650417"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5041-7_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"14 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"S\u00e9bastien Menant, Damien Nevoltris, and Romain Ollier are employees of AC Immune and are entitled to options and\/or shares. This study was funded by AC Immune SA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}